甲状腺乳头状癌与桥本甲状腺炎关系研究进展
Research Progress on the Relationship between Thyroid Papillary Carcinoma and Hashimoto’s Thyroiditis
DOI: 10.12677/ACM.2022.126808, PDF,   
作者: 樊艺璇：青海大学研究生院，青海 西宁；张雪云*：青海大学附属医院乳腺甲状腺肿瘤外科，青海 西宁
关键词: 甲状腺乳头状癌；桥本甲状腺炎；发病机制；Papillary Thyroid Carcinoma； Hashimoto’s Thyroiditis； Pathogenesis
摘要: 随着医学技术水平的不断提高，临床工作中甲状腺癌和桥本甲状腺炎的检出率逐年上升，甲状腺乳头状癌作为甲状腺癌中发病率最高的恶性肿瘤，合并桥本甲状腺炎的甲状腺乳头状癌患者也越来越多。关于二者之间有无相关性及桥本甲状腺炎是否可被称之为甲状腺乳头状癌的癌前病变，目前对此尚无确切说法。本文将对甲状腺乳头状癌合并桥本氏甲状腺炎疾病的流行病学、组织病理学特点和发生机制展开综述，为临床医学诊断和治疗提供依据。
Abstract: With the continuous improvement of medical technology, the detection rate of thyroid cancer and Hashimoto’s thyroiditis in clinical work is increasing year by year. As the malignant tumor with the highest incidence of thyroid cancer, the number of patients with thyroid papillary carcinoma com-plicated with Hashimoto’s thyroiditis is also increasing. It is unclear whether there is a correlation between the two and whether Hashimoto’s thyroiditis can be called a precancerous lesion of thyroid papillary carcinoma. This article reviews the epidemiology, histopathological features and patho-genesis of papillary thyroid carcinoma complicated with Hashimoto’s thyroiditis, providing evi-dence for clinical diagnosis and treatment.
文章引用：樊艺璇, 张雪云. 甲状腺乳头状癌与桥本甲状腺炎关系研究进展[J]. 临床医学进展, 2022, 12(6): 5591-5596. https://doi.org/10.12677/ACM.2022.126808

参考文献

[1] De Groot, L.J. (1975) Thyroid Carcinoma. Medical Clinics of North America, 59, 1233-1246. [Google Scholar] [CrossRef] 
[2] Graceffa, G., Patrone, R., Vieni, S., Campanella, S., Calamia, S., Laise, I., Conzo, G., Latteri, M. and Cipolla, C. (2019) Association between Hashimoto’s Thyroiditis and Papillary Thyroid Carcinoma: A Retrospective Analysis of 305 Patients. BMC Endocrine Disorders, 19, Article No. 26. [Google Scholar] [CrossRef] [PubMed]
[3] Pyzik, A., Grywalska, E., Matyjaszek-Matuszek, B. and Roliński, J. (2015) Immune Disorders in Hashimoto’s Thyroiditis: What Do We Know So Far? Journal of Immunology Research, 2015, Article ID: 979167. [Google Scholar] [CrossRef] [PubMed]
[4] 高嘉良, 袁方均, 武伦, 高云龙, 苟志敏. 桥本甲状腺炎对甲状腺乳头状癌的影响[J]. 锦州医科大学学报, 2021, 42(3): 83-86. [Google Scholar] [CrossRef] 
[5] Intidhar, L.S., Chaabouni, A.M., Kraiem, T., Attia, N., Gritli, S., El May, A. and Ben Slimane, F. (2006) Carcinome de la thyroïde et thyroïdite de Hashimoto [Thyroid Carci-noma and Hashimoto Thyroiditis]. Annales d’oto-laryngologie et de Chirurgie Cervico Faciale, 123, 175-178. (In French) [Google Scholar] [CrossRef] 
[6] Dailey, M.E., Lindsay, S. and Skahen, R. (1955) Relation of Thyroid Neoplasms to Hashimoto Disease of the Thyroid Gland. Archives of Surgery, 70, 291-297. [Google Scholar] [CrossRef] [PubMed]
[7] Hussain, S.P. and Haris, C.C. (2007) Inflammation and Cancer: An Aryist Link with Novel Potentials. International Journal of Cancer, 121, 2373-2380. [Google Scholar] [CrossRef] [PubMed]
[8] Jankovic, B., Le, K.T. and Hershman, J.M. (2013) Clinical Review: Hash-imoto’s Thyroiditis and Papillary Thyroid Carcinoma: Is There a Correlation? The Journal of Clinical Endocrinology & Metabolism, 98, 474-482. [Google Scholar] [CrossRef] [PubMed]
[9] Tokić, S., Štefanić, M., Karner, I. and Glavaš-Obrovac, L. (2017) Al-tered Expression of CTLA-4, CD28, VDR, and CD45 mRNA in T Cells of Patients with Hashimoto’s Thyroiditis—A Pilot Study. Endokrynologia Polska, 68, 274-828. [Google Scholar] [CrossRef] 
[10] 刘三保, 陈斌. 桥本甲状腺炎合并甲状腺癌与免疫细胞的相关性研究进展[J]. 辽宁医学院学报, 2015, 36(3): 107-109.
[11] Zahran, A.M., Sayed, M.M., Shafik, E.A., Khallaf, S.M., Mohamed, W.M. and Hetta, H.F. (2019) The Frequency and Clinical Implications of Lymphocyte Subsets and Circulat-ing Plasma Cells in Newly Diagnosed Multiple Myeloma Patients. Egyptian Journal of Immunology, 26, 117-131.
[12] Lyu, Y., Song, M., Tian, X., Yu, X., Liang, N. and Zhang, J. (2020) Impact of Radiotherapy on Circulat-ing Lymphocyte Subsets in Patients with Esophageal Cancer. Medicine (Baltimore), 99, e20993. [Google Scholar] [CrossRef] 
[13] Ben-Skowronek, I., Szewczyk, L., Kulik-Rechberger, B. and Korobowicz, E. (2013) The Differences in T and B Cell Subsets in Thyroid of Children with Graves’ Disease and Hashimoto’s Thyroiditis. World Journal of Pediatrics, 9, 245-250. [Google Scholar] [CrossRef] [PubMed]
[14] Xu, X., Wang, R., Su, Q., Huang, H., Zhou, P., Luan, J., Liu, J., Wang, J. and Chen, X. (2016) Expression of Th1- Th2- and Th17-Associated Cytokines in Laryngeal Carcinoma. On-cology Letters, 12, 1941-1948. [Google Scholar] [CrossRef] [PubMed]
[15] 寿岚, 任跃忠. 桥本甲状腺炎的免疫学研究进展[J]. 浙江医学, 2014, 36(4): 343-345.
[16] 叶旺. 合并桥本氏甲状腺炎的甲状腺乳头状癌的临床病理特点及颈部淋巴结转移风险分析[D]: [硕士学位论文]. 南宁: 广西医科大学, 2019.
[17] 朱利国, 浦洪波, 武红玉, 李跃松, 陈永伟. 促甲状腺激素、甲状腺过氧化物酶抗体和促甲状腺激素受体抗体检测在甲状腺疾病中的应用价值[J]. 标记免疫分析与临床, 2010, 17(4): 241-243.
[18] Liu, Y., Lyu, H., Zhang, S., Shi, B. and Sun, Y. (2021) The Impact of Coexistent Hashimo-to’s Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma. Frontiers in Endo-crinology (Lausanne), 12, Article ID: 772071. [Google Scholar] [CrossRef] [PubMed]
[19] 郑旭东. 桥本氏病患者血清促甲状腺激素水平升高对甲状腺组织癌变的影响[J]. 实用癌症杂志, 2018, 33(3): 395-397.
[20] Liang, J., Zeng, W., Fang, F., Yu, T., Zhao, Y., Fan, X., Guo, N. and Gao, X. (2017) Clinical Analysis of Hashimoto Thyroidi-tis Coexistent with Papillary Thyroid Cancer in 1392 Patients. Acta Otorhinolaryngologica Italica, 37, 393-400. [Google Scholar] [CrossRef] 
[21] 彭学姣, 许天敏, 张琨, 赵生炳, 史莹, 常伟勤. 雌激素与甲状腺癌相关性的研究进展[J]. 现代肿瘤医学, 2018, 26(11): 1791-1794.
[22] 王贵生, 赵金凤. 雌激素受体在自身免疫性甲状腺炎中的表达[J]. 中国误诊学杂志, 2008(10): 2298-2299.
[23] Ikawa, S., Fukui, M., Ueyama, Y., Tamao-ki, N., Yamamoto, T. and Toyoshima, K. (1988) B-raf, a New Member of the Raf Family, Is Activated by DNA Rear-rangement. Molecular and Cellular Biology, 8, 2651-2654. [Google Scholar] [CrossRef] 
[24] 王欣怡, 白俊文. 甲状腺癌的相关基因BRAF、RET、RAS研究新进展[J]. 重庆医学, 2018, 47(36): 4631-4634.
[25] Rhoden, K.J., Unger, K., Salvatore, G., Yilmaz, Y., Vovk, V., Chiappetta, G., Qumsiyeh, M.B., Rothstein, J.L., Fusco, A., Santoro, M., Zitzelsberger, H. and Tallini, G. (2006) RET/Papillary Thyroid Cancer Rearrangement in Nonneoplastic Thyrocytes: Follicular Cells of Hashimoto’s Thyroiditis Share Low-Level Recombination Events with a Subset of Papillary Carcinoma. The Journal of Clinical Endocrinology & Metabolism, 91, 2414-2423. [Google Scholar] [CrossRef] [PubMed]
[26] 姜海霞, 李艳波. 碘对甲状腺疾病影响及机制的研究进展[J]. 中华实用诊断与治疗杂志, 2016, 30(7): 639-641. [Google Scholar] [CrossRef] 
[27] Iddah, M.A. and Macharia, B.N. (2013) Autoimmune Thyroid Disorders. ISRN Endocrinology, 2013, Article ID: 509764. [Google Scholar] [CrossRef] [PubMed]
[28] 董芬, 张彪, 单广良. 中国甲状腺癌的流行现状和影响因素[J]. 中国癌症杂志, 2016, 26(1): 47-52.
[29] Hatch, M., Furukawa, K., Brenner, A., Olinjyk, V., Ron, E., Zablotska, L., Terekhova, G., McConnell, R., Markov, V., Shpak, V., Ostroumova, E., Bouville, A. and Tronko, M. (2010) Prevalence of Hyperthyroidism after Exposure during Childhood or Adolescence to Radioiodines from the Chornobyl Nuclear Accident: Dose-Response Results from the Ukraini-an-American Cohort Study. Radiation Research, 174, 763-772. [Google Scholar] [CrossRef] 

为你推荐